Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme

NCT04930185 | Unknown

• 1 other identifier: SRB/IIR/SMC/F/21/001
• Study Type: interventional
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

The COVID-19 pandemic has spread to over 200 countries worldwide and is still on the rise in 88 countries. Unfortunately, Malaysia is not the exception and registered 340,642 COVID-19 cases till 29 March 2021 since the outbreak of the pandemic. COVID-19 virus can be transmitted from an infected person to others through droplets when coughing or sneezing as well as by touching objects infected with the virus. Although precautionary measures, which include the regular and mandatory use of face masks, reducing crowds, and physical distancing, have been widely encouraged by WHO and the Malaysian government, getting COVID-19 vaccination remain the way forward to curb the wide spread of the virus and to return to the normal. However, the public awareness on the importance of getting vaccinated is still low with high level of vaccination hesitance and refusal. In Malaysia, this challenge is compounded further due to a lack of COVID-19 vaccination educational intervention programme in Bahasa Malaysia to educate the predominantly larger group in the population who are more conversant in ther national language. In order to improve the acceptance rate towards the COVID-19 vaccination in Malaysia, it is imperative to design a comprehensive intervention program that will increase the awareness and knowledge with regards to the efficacy of the COVID-19 vaccine as a solution in overcoming this pandemic. With this in mind, this study aims to identify the correlational factors of COVID-19 and develop an educational intervention programme on COVID-19 vaccination and thereafter, assess the effectiveness of this educational intervention programme.

Conditions

COVID-19 Vaccination

Outcome Measures

Primary Outcomes (1)

• Reducing Vaccine Hesitancy

  The vaccine hesitancy scale

  17 months

Secondary Outcomes (1)

• Reducing Vaccine Hesitancy

  17 months

Study Arms (3)

Pamphlet

EXPERIMENTAL

Participants will received pamphlet about COVID-19 vaccination

Behavioral: Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): An Educational Intervention Programme

Webinar

EXPERIMENTAL

Participants will received webinar about COVID-19 vaccination

Behavioral: Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): An Educational Intervention Programme

SMS

EXPERIMENTAL

Participants will received SMS about COVID-19 vaccination

Behavioral: Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): An Educational Intervention Programme

Interventions

Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): An Educational Intervention Programme BEHAVIORAL

Participants will be receiving the pamphlet about the COVID-19 vaccination information during the intervention. They will received 3 different sets of questionnaire to measured their level of vaccine hesitancy and vaccine refusal in 3 different time points: (a) before intervention, (b) after the intervention, and (c) 3 months after the intervention. Data cleansing will be conducted based on the per-protocol analysis. Pre-protocol is a comparison of treatment groups that includes only those patients who completed the treatment originally allocated.

Pamphlet

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Individuals aged 18 years and above
• Able to provide informed consent (verbal/written) to participate
• Understand either Bahasa Malaysia
• Participants who have not received their COVID-19 vaccination
• Participants who have access to smart phone and/or mobile phone
• Participants who have access to internet.

You may not qualify if:

• Those who have had any prior history of psychological or neurological illness

Sponsors & Collaborators

• Sunway University: lead

Study Sites (1)

Sunway University

Petaling Jaya, Selangor, 47500, Malaysia

Location

Central Study Contacts

Pei Boon Ooi, Doctorate

CONTACT

03-74918622; peiboono@sunway.edu.my

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Teaching Fellow

Study Record Dates

• First Submitted: June 3, 2021
• First Posted: June 18, 2021
• Study Start: September 1, 2021
• Primary Completion: December 31, 2022
• Study Completion: January 31, 2023
• Last Updated: June 18, 2021

Record last verified: 2021-06

Locations

MY (1)